Stoyanova Lab
  • Home
  • Research
  • Our Group
  • Alumni
  • Publications
  • News
  • Join Our Team
  • Donate
    • Sponsors
  • Contact
Stoyanova Lab
  • Home
  • Research
  • Our Group
  • Alumni
  • Publications
  • News
  • Join Our Team
  • Donate
    • Sponsors
  • Contact

Discovery of ferroptosis inducers as a new therapeutic strategy for advanced prostate cancer

January 10, 2021

New study from our lab demonstrates that ferroptosis inducers represent a new therapeutic approach for advanced prostate cancer.

https://cancerres.aacrjournals.org/content/81/6/1583.long

January 10, 2021

NewsStanford

FacebookXPinterestRedditDeliciousWhatsappEmail
  • PreviousIdentification of a new serum biomarker for clinically significant prostate cancer

  • NextDr. Demirci and Dr. Stoyanova receive Spectrum MedTech Pilot Grant

Related Posts ...

Exciting news: Dr. Hyeonji Hwang, a postdoctoral fellow at Dr. Stoyanova’s Lab in UCLA, awarded the Prostate Cancer Research Program Early Investigator Research Award by the US Department of Defense (DOD) for the project titled “Targeting Trop2-Mediated Ferroptosis as a New Therapy for Advanced Prostate Cancer”

News, UCLA

Exciting News: Dr. Tanya Stoyanova receives 2025 Neuroendocrine Tumor Research Foundation Pilot Award

News, UCLA

Logo

ADDRESS

Los Angeles
CA 90095, USA
tstoyanova@mednet.ucla.edu

+1 (310) 825 0955

QUICK LINKS

  • UCLA
  • UCLA Health
  • Positions Available
© Stoyanova Lab. All Rights Reserved. | admin login